How to get tested for APOE4, and whether you should

Finding out your APOE status is easy and cheap. The harder question is whether you want to know at all, because once you do, you cannot undo it. This page lays out the three ways to get tested, what each one costs and is good for, the trade-offs that rarely get spelled out (insurance is the big one), and a clear way to decide before you look.

Start with the decision, not the test. The single most important thing to settle first is this: what would you actually do differently with the answer? If the honest reply is “nothing I’m not already doing,” you can skip the test and just work the levers. If the answer would change real plans, read on.

The three ways to get tested

There are three routes to your APOE genotype, and they differ in cost, accuracy, and whether a doctor can act on the result.

Route	Typical cost	Result quality	Best for
Consumer DNA kit	$99 to $199	Research-grade, not CLIA-certified	Curiosity, a cheap first look
Clinical genetic test	$50 to $200 out of pocket, often covered by insurance	CLIA-certified, usable in care	A result that might change decisions
Research study (e.g. GeneMatch)	Free	Varies; often not disclosed to you	Trial matching, not learning your status

Here is what each one actually involves.

Direct-to-consumer DNA kits. Services like 23andMe (typically $99 to $199 for an ancestry-plus-health kit) report APOE variants directly as an opt-in “health” feature. Others give you raw data you read yourself, though coverage varies, and AncestryDNA files frequently omit one of the two SNPs you need. Convenient and cheap, but the results are research-grade, not CLIA-certified, which means they arrive without clinical context and are not meant to drive medical decisions on their own. For the hands-on version, see find your APOE status in your 23andMe or AncestryDNA data.

Clinical genetic testing. Ordered through a doctor or genetic counselor, usually with counseling before and after. It runs through a CLIA-certified lab (Quest, Labcorp), so the result can actually be used in medical decision-making. Out of pocket it is typically $50 to $200, and often less or fully covered when insurance applies. This is the route most experts recommend if the result might affect real decisions.

Research studies. Some Alzheimer’s prevention studies test APOE as part of enrollment. The GeneMatch program (run by the Alzheimer’s Prevention Registry, for U.S. adults aged 55 to 75) genotypes you from a cheek swab to match you to trials, but it does not disclose your APOE result to you. Whether results are shared otherwise varies by study; see finding a prevention trial.

The case for knowing

For the right person, a result is genuinely useful.

• Motivation. A concrete result is, for some people, the push to take modifiable risk factors seriously while there is the most time to act.
• Planning. It can sharpen conversations about screening, lifestyle, and long-term planning.
• Research and treatment relevance. Some prevention trials specifically seek carriers, and genotype now matters for the safety of anti-amyloid drugs if Alzheimer’s is ever diagnosed.

The case for caution

The reasons to pause are real, and worth weighing honestly.

• It is a risk factor, not a diagnosis. APOE4 raises your odds. It does not tell you whether or when you will develop disease, and there is no APOE-specific treatment to “fix” it. See what the numbers mean.
• The emotional side is real, but more manageable than people fear. Learning you are a carrier can cause genuine anxiety, and you cannot unknow it. Here the evidence is reassuring: the REVEAL randomized trials, which actually disclosed APOE status to people, found that most carriers did not experience lasting distress, and some adopted more health-protective behaviors. Pre-test counseling exists precisely to prepare you for any result.
• Insurance is the trade-off that catches people off guard. In the U.S., GINA protects you from discrimination by health insurers and most employers, but it does not cover life, disability, or long-term-care insurance. Some people lock in that coverage before testing. Rules differ by country and state, so know your situation first.
• Privacy. Think about where the data, and the fact that you tested, will live, especially with consumer services and any third-party tool you upload raw data to. See our privacy page.

How to decide: a four-step framework

Walk these in order. The first one does most of the work.

1. Name what you would do differently with the result, concretely. If the honest answer is “nothing I’m not already doing,” testing may add anxiety without adding action.
2. Consider genetic counseling first. It is especially helpful before testing, and strongly advised if you have a strong family history. A counselor can put APOE in context, discuss rarer high-impact genes, and prepare you for either result. The NSGC directory lists counselors.
3. Sort out insurance if life, disability, or long-term-care coverage matters to you. Do this before, not after.
4. Plan to interpret it with a clinician, not a forum. APOE is one input among many, and the context is where the value is.

Common questions

Will my health insurer raise my rates if I test positive? No. In the U.S., GINA prohibits health insurers from using genetic information against you. The gap is life, disability, and long-term-care insurance, which GINA does not cover.

Do I need a doctor, or is a DNA kit enough? A kit can tell you the genotype, but if the result would drive real decisions, confirm and interpret it clinically. Kits are a starting point, not the final word.

Is it better not to know? For some people, yes. If a result would cause distress without changing your actions, it is entirely reasonable to skip testing and just work the levers.

The highest-leverage actions, exercise, cardiovascular health, sleep, and diet, are worth doing regardless of your genotype. Testing can motivate, but it is not a prerequisite for getting started. This is general education, not medical advice.